123 related articles for article (PubMed ID: 1980821)
1. Trends in survival of Danish AIDS patients from 1981 to 1989.
Pedersen C; Gerstoft J; Tauris P; Lundgren JD; Gøtzsche PC; Buhl M; Salim Y; Schmidt K; Nielsen JO
AIDS; 1990 Nov; 4(11):1111-6. PubMed ID: 1980821
[TBL] [Abstract][Full Text] [Related]
2. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984-1991.
Jacobson LP; Kirby AJ; Polk S; Phair JP; Besley DR; Saah AJ; Kingsley LA; Schrager LK
Am J Epidemiol; 1993 Dec; 138(11):952-64. PubMed ID: 7903022
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
4. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: St Stephen's Hospital experience.
Stambuk D; Hawkins D; Gazzard BG
J Infect; 1989 Jan; 18 Suppl 1():41-51. PubMed ID: 2492585
[TBL] [Abstract][Full Text] [Related]
5. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993.
Osmond D; Charlebois E; Lang W; Shiboski S; Moss A
JAMA; 1994 Apr; 271(14):1083-7. PubMed ID: 7908703
[TBL] [Abstract][Full Text] [Related]
6. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.
Easterbrook PJ; Yu LM; Goetghebeur E; Boag F; McLean K; Gazzard B
AIDS; 2000 Mar; 14(5):561-71. PubMed ID: 10780719
[TBL] [Abstract][Full Text] [Related]
7. Survival and treatment of AIDS patients 1984-1993: experience of a smaller east London HIV centre.
Hillman RJ; Beck EJ; Mandalia S; Satterthwaite H; Rogers PA; Forster GE; Goh BT
Genitourin Med; 1997 Feb; 73(1):44-8. PubMed ID: 9155555
[TBL] [Abstract][Full Text] [Related]
8. Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up. The Danish Study Group for HIV Infection (DASHI).
Lundgren JD; Melbye M; Pedersen C; Rosenberg PS; Gerstoft J
Am J Epidemiol; 1995 Apr; 141(7):652-8. PubMed ID: 7702040
[TBL] [Abstract][Full Text] [Related]
9. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
[TBL] [Abstract][Full Text] [Related]
10. Trends and patterns of opportunistic diseases in Danish AIDS patients 1980-1990.
Smith E; Orholm M
Scand J Infect Dis; 1990; 22(6):665-72. PubMed ID: 2135639
[TBL] [Abstract][Full Text] [Related]
11. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study.
Graham NM; Zeger SL; Park LP; Phair JP; Detels R; Vermund SH; Ho M; Saah AJ
Lancet; 1991 Aug; 338(8762):265-9. PubMed ID: 1677108
[TBL] [Abstract][Full Text] [Related]
12. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
13. [AIDS in Denmark. 2. Survival after the diagnosis of AIDS. Danish Study Group for HIV infection].
Lundgren JD; Pedersen C; Bentsen KD; Gerstoft J; Seefeldt-Nielsen T; Nielsen TL; Jensen GF
Ugeskr Laeger; 1995 Mar; 157(10):1352-6. PubMed ID: 7709483
[TBL] [Abstract][Full Text] [Related]
14. Survival trends for patients with AIDS.
Lemp GF; Payne SF; Neal D; Temelso T; Rutherford GW
JAMA; 1990 Jan; 263(3):402-6. PubMed ID: 2294307
[TBL] [Abstract][Full Text] [Related]
15. Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients.
Vella S; Giuliano M; Floridia M; Chiesi A; Tomino C; Seeber A; Barcherini S; Bucciardini R; Mariotti S
AIDS; 1995 Jan; 9(1):51-6. PubMed ID: 7893441
[TBL] [Abstract][Full Text] [Related]
16. CD4+ lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time.
Graham NM; Piantadosi S; Park LP; Phair JP; Rinaldo CR; Fahey JL
J Acquir Immune Defic Syndr (1988); 1993 Nov; 6(11):1258-66. PubMed ID: 7901384
[TBL] [Abstract][Full Text] [Related]
17. Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection.
Nightingale SD; Jockusch JD; Haslund I; Cal SX; Peterson DM; Loss SD
Arch Intern Med; 1993 Jun; 153(11):1313-8. PubMed ID: 8099477
[TBL] [Abstract][Full Text] [Related]
18. Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group.
Easterbrook PJ; Keruly JC; Creagh-Kirk T; Richman DD; Chaisson RE; Moore RD
JAMA; 1991 Nov; 266(19):2713-8. PubMed ID: 1942423
[TBL] [Abstract][Full Text] [Related]
19. The effects on survival of early treatment of human immunodeficiency virus infection.
Graham NM; Zeger SL; Park LP; Vermund SH; Detels R; Rinaldo CR; Phair JP
N Engl J Med; 1992 Apr; 326(16):1037-42. PubMed ID: 1347907
[TBL] [Abstract][Full Text] [Related]
20. Evolving trends revealed by autopsies of patients with the acquired immunodeficiency syndrome. 565 autopsies in adults with the acquired immunodeficiency syndrome, Los Angeles, Calif, 1982-1993 [corrected].
Klatt EC; Nichols L; Noguchi TT
Arch Pathol Lab Med; 1994 Sep; 118(9):884-90. PubMed ID: 8080357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
